首页> 外国专利> NITROGEN Heterocycles derived Compound, Pharmaceutical composition comprising such a compound; and use of the composition for the treatment of Metabolic Disorders such as obesity,Diabetes, anorexia, bulimia, Hypo and hyperglycemia, dislip

NITROGEN Heterocycles derived Compound, Pharmaceutical composition comprising such a compound; and use of the composition for the treatment of Metabolic Disorders such as obesity,Diabetes, anorexia, bulimia, Hypo and hyperglycemia, dislip

机译:氮杂环衍生的化合物,包含该化合物的药物组合物;剂及其在代谢性疾病如肥胖症,糖尿病,厌食症,贪食症,低血糖和高血糖症,疾病中的应用

摘要

The present invention provides new organic compounds of the following formula: €ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒA-L1-B-C-D-L2-E wherein A, L1, B, C, D, L2 and E are as defined in the description of the invention, that are useful for treating or preventing conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions comprising such compounds.
机译:本发明提供下式的新有机化合物:A-L1-B-C-D-L2-E其中A,L1,B,C,D,L2和E如本发明说明书中所定义,其可用于治疗或预防与DGAT1活性有关的病症或疾病,特别是2型糖尿病,以及包含此类化合物的药物组合物。

著录项

  • 公开/公告号CL2007000885A1

    专利类型

  • 公开/公告日2008-05-23

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号CL20070000885

  • 申请日2007-03-30

  • 分类号A61K31/44;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P35/00;C07D213/74;C07D213/75;C07D213/81;C07D213/82;C07D237/20;C07D239/42;C07D263/48;C07D277/42;C07D401/12;C07D401/14;C07D405/12;C07D413/10;C07D413/12;C07D213/30;

  • 国家 CL

  • 入库时间 2022-08-21 20:08:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号